A 1 Stock Price Today (NSE: AIL)
Fundamental Score
A 1 Share Price — Live NSE/BSE Price, Fundamentals & Analysis
A 1 share price today is ₹40.00, up +0.00% on NSE/BSE as of 19 June 2026. A 1 (AIL) is a Small-cap company in the Trading - Chemicals sector with a market capitalisation of ₹3.08K (Cr). The 52-week high for AIL share price is ₹75.00 and the 52-week low is ₹23.75. At a P/E ratio of 1225.94x, AIL is currently trading above its industry average P/E of 65.53x. The company has a Return on Equity (ROE) of 7.82% and a debt-to-equity ratio of 0.35.
A 1 Share Price Chart — NSE/BSE Historical Performance
A 1 share price chart: 6.52% return over the past month. 52-week high ₹75.00, 52-week low ₹23.75.
A 1 — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹40.00 | ₹40.00 | ₹40.00 | ₹40.00 | 1.50K (Cr) | |
| ₹42.00 | ₹42.00 | ₹42.00 | ₹42.00 | 3.00K (Cr) | |
| ₹44.10 | ₹44.10 | ₹44.10 | ₹44.10 | 0.00 (Cr) | |
| ₹44.10 | ₹44.10 | ₹44.10 | ₹44.10 | 0.00 (Cr) | |
| ₹44.10 | ₹44.10 | ₹44.10 | ₹44.10 | 0.00 (Cr) | |
| ₹42.00 | ₹42.00 | ₹42.00 | ₹42.00 | 0.00 (Cr) | |
| ₹42.00 | ₹42.00 | ₹42.00 | ₹42.00 | 0.00 (Cr) | |
| ₹42.00 | ₹42.00 | ₹42.00 | ₹42.00 | 0.00 (Cr) | |
| ₹42.00 | ₹42.00 | ₹42.00 | ₹42.00 | 0.00 (Cr) | |
| ₹42.00 | ₹42.00 | ₹42.00 | ₹42.00 | 1.50K (Cr) |
A 1 — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹40.00 | ₹40.00 | ₹40.00 | ₹40.00 | +0.00% | |
| ₹41.40 | ₹44.50 | ₹41.40 | ₹42.00 | +1.45% | |
| ₹34.20 | ₹41.40 | ₹29.70 | ₹41.40 | +21.05% | |
| ₹36.55 | ₹43.90 | ₹35.10 | ₹36.00 | -1.50% | |
| ₹24.90 | ₹36.55 | ₹23.75 | ₹36.55 | +46.79% | |
| ₹39.00 | ₹39.00 | ₹26.20 | ₹26.20 | -32.82% | |
| ₹43.70 | ₹43.70 | ₹39.60 | ₹40.00 | -8.47% | |
| ₹40.60 | ₹47.50 | ₹40.60 | ₹43.70 | +7.64% | |
| ₹39.00 | ₹42.20 | ₹36.70 | ₹40.60 | +4.10% | |
| ₹42.95 | ₹45.00 | ₹38.85 | ₹40.00 | -6.87% | |
| ₹58.80 | ₹61.00 | ₹39.85 | ₹45.20 | -23.13% | |
| ₹69.15 | ₹69.15 | ₹57.00 | ₹58.80 | -14.97% |
AI Research Briefing
Powered by Gemini · 2026-04-17
AIL is a momentum-driven small-cap with stretched valuation and poor recent performance; this rally will end badly.
WHAT'S HAPPENING NOW (last 2-4 weeks)
A 1 (AIL) has seen its stock price surge 45.51% in the last month and 195.39% in the last 3 months . No specific news events like order wins or earnings reports have been found in the last month .
CORE STORY (THE REAL GAME)
AIL is a small-cap trading company in the chemicals sector, and the market seems to be pricing in a turnaround or speculative growth despite weak fundamentals. The stock's performance is detached from its earnings, suggesting a narrative-driven rally rather than a fundamentals-based one.
- Recent price surge of 45.51% in 1 month indicates strong upward momentum [cite: brief]
- Small-cap stocks are currently in favor with retail investors
- Overall positive sentiment in the Indian market
- Significant order wins or contracts
- Positive earnings surprise
- Major acquisition or expansion announcement
- Extremely high P/E ratio of 1225.94x compared to the industry average of 65.53x [cite: brief]
- Negative free cash flow of ₹-1.96 Cr over the past 5 years [cite: brief]
- Latest quarter YoY profit declined by -92.78% and sales declined by -18.8% [cite: brief]
FII holdings have increased slightly by 0.23%, while DII holdings remain at 0.0% [cite: brief]. Promoter holding is stable at 70.03% [cite: brief].
The Indian chemical industry is projected to grow, but AIL's weak fundamentals make it a risky play.
No - Free Cash Flow 5Y: ₹-1.96 Cr [cite: brief]
The stock's future depends on a significant turnaround in its financial performance, which is highly uncertain. Expect a correction if earnings don't catch up to the valuation.
Primary Thesis Risk
Overvaluation and poor financial performance make this stock highly vulnerable to a correction.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
A 1 Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
A 1 Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AIL across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Consistent Growth Track Record (23.45% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Balanced Promoter Holding (70.03%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (7.82%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Margin Pressure Concerns (2.40%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 1225.94x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-92.78%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-18.80%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (3.75% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (3.75% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-1.96 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 6.03%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
A 1 vs Trading - Chemicals Peers
Peer Comparison - Trading - Chemicals
Compare A 1 with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
A 1A 1...Selected✓ AIL • 542012 | 25.9/100 | ₹40.00₹40 | ₹3077.11₹3077.11 | 1225.94Average 1225.9 Average | 7.82%Poor 7.82% Poor | 10.63%Average 10.63% Average | 0.35Excellent 0.3 Excellent | 3.75%Average 3.75% Average | 23.45%Excellent 23.45% Excellent | 0.06% |
Uniphos Enterprises LtdUniphos Enterpr... UNIENTER • 500429 | 36.1/100 | ₹106.52₹107 | ₹976.12₹976.12 | 51.43Average 51.4 Average | 0.01%Poor 0.01% Poor | 0.06%Poor 0.06% Poor | 0.00Excellent 0.0 Excellent | -57.73%Poor -57.73% Poor | 244.44%Excellent 244.44% Excellent | 0.35% |
Vinyl Chemicals India LtdVinyl Chemicals... VINYLINDIA • 524129 | 59.6/100 | ₹264.10₹264 | ₹451.64₹451.64 | 23.03Average 23.0 Average | 15.57%Good 15.57% Good | 21.12%Excellent 21.12% Excellent | 0.00Excellent 0.0 Excellent | 24.13%Excellent 24.13% Excellent | 10.92%Good 10.92% Good | 2.82% |
59.8/100 | ₹40.86₹41 | ₹430.15₹430.15 | 35.88Average 35.9 Average | 10.94%Average 10.94% Average | 14.08%Average 14.08% Average | 0.15Excellent 0.1 Excellent | 33.46%Excellent 33.46% Excellent | 24.82%Excellent 24.82% Excellent | 0.07% | |
Shiv Texchem LtdShiv Texchem Lt... SHIVTEXCHEM • 544272 | 42.5/100 | ₹156.05₹156 | ₹405.51₹405.51 | 5.76Average 5.8 Average | 18.30%Good 18.30% Good | 14.46%Average 14.46% Average | 1.15Average 1.1 Average | — — | — — | 0.00% |
Evexia Lifecare LtdEvexia Lifecare... EVEXIA • 524444 | 0/100 | ₹1.15₹1 | ₹332.28₹332.28 | 232.37Average 232.4 Average | 0.32%Poor 0.32% Poor | 0.30%Poor 0.30% Poor | 2.16Poor 2.2 Poor | -23.15%Poor -23.15% Poor | 1.97%Average 1.97% Average | 0.00% |
27.7/100 | ₹31.15₹31 | ₹315.31₹315.31 | 79.62Average 79.6 Average | 16.42%Good 16.42% Good | 18.53%Good 18.53% Good | 0.37Excellent 0.4 Excellent | — — | — — | 0.00% | |
Yash Chemex LtdYash Chemex Ltd... YASHCHEM • 539939 | 34.7/100 | ₹53.87₹54 | ₹94.46₹94.46 | 53.67Average 53.7 Average | 5.60%Poor 5.60% Poor | 8.13%Poor 8.13% Poor | 0.35Excellent 0.3 Excellent | -2.94%Poor -2.94% Poor | 3.96%Average 3.96% Average | 0.00% |
Mysore Petro Chemicals LtdMysore Petro Ch... MYSORPETRO • 506734 | 35/100 | ₹102.00₹102 | ₹67.88₹67.88 | 8.22Average 8.2 Average | 1.30%Poor 1.30% Poor | 7.82%Poor 7.82% Poor | 0.00Excellent 0.0 Excellent | -8.99%Poor -8.99% Poor | 20.87%Excellent 20.87% Excellent | 1.94% |
Laffans Petrochemicals LtdLaffans Petroch... LAFFANSQ • 524522 | 19.6/100 | ₹27.28₹27 | ₹26.92₹26.92 | — — | 1.69%Poor 1.69% Poor | 2.30%Poor 2.30% Poor | 0.01Excellent 0.0 Excellent | 17.45%Excellent 17.45% Excellent | -7.70%Poor -7.70% Poor | 0.00% |
Citichem India LtdCitichem India ... CITICHEM • 544324 | 54.6/100 | ₹18.00₹18 | ₹17.34₹17.34 | 9.69Average 9.7 Average | 8.91%Poor 8.91% Poor | 11.56%Average 11.56% Average | 0.34Excellent 0.3 Excellent | 43.81%Excellent 43.81% Excellent | -15.65%Poor -15.65% Poor | 0.00% |
Top Trading - Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Uniphos Enterprises Ltd share price976.12 Cr
- Vinyl Chemicals India Ltd share price451.64 Cr
- Shankar Lal Rampal Dye Chem Ltd share price430.15 Cr
- Shiv Texchem Ltd share price405.51 Cr
- Evexia Lifecare Ltd share price332.28 Cr
A 1 Quarterly Performance
Latest quarterly metrics for AIL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-18.80%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-92.78%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
23.45%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
3.75%
Compounded annual net profit growth over 5 years
A 1 Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AIL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
A 1 Financial Statements
Annual income statement, balance sheet and cash flow for A 1 (AIL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for A 1
About AIL (A 1)
A 1 (AIL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Trading - Chemicals sector with a current market capi...talisation of ₹3.08K (Cr). A 1 has delivered a Return on Equity (ROE) of 7.82% and a ROCE of 10.63%. The debt-to-equity ratio stands at 0.35, reflecting the company's capital structure. Investors tracking AIL share price can monitor key metrics including P/E ratio, promoter holding of 70.03%, and quarterly earnings growth.
Company Details
Latest News
AIL Share Price: Frequently Asked Questions
What is the current share price of A 1?
A 1 (AIL) trades at ₹40.00 on NSE and BSE. Market cap ₹3.08K (Cr). Educational data only.
What is the P/E ratio of A 1?
A 1 has a P/E of 1225.94x vs industry average 65.53x.
What is the Bull Run score for A 1?
A 1 has a Bull Run score of 25.9/100 based on 25+ financial parameters.
Does A 1 pay dividends?
A 1 has a dividend yield of 0.06%. Past dividends don't guarantee future payments.
What is the ROE of A 1?
A 1 has ROE of 7.82%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of A 1?
A 1 has debt-to-equity of 0.35.
Is A 1 a good investment?
Bull Run gives A 1 a score of 25.9/100. This is not investment advice — consult a SEBI-registered advisor.